PresentationStephanie ParisVice President of Investor Relations & Corporate Strategy Good morning, everyone, and welcome to TransAlta's 2026 Investor Day. My name is Stephanie Paris, and I'm the Vice President of Investor Relations and Corporate Strategy. We're very pleased to have you all here with us in Toronto and joining us virtually as well. Today's presentation is being recorded, and a replay of the event and transcript will be posted on our website. As we begin our session, please note that this pre ...

Core Viewpoint - Graphene Manufacturing Group Limited (GMG) is advancing its Gen 2.0 Graphene Manufacturing Technology plant, with an additional investment of AU$1.4 million approved to complete construction, aiming for a production capacity of 10 tons of graphene per year [1][2]. Group 1: Gen 2.0 Plant Development - The total estimated capital cost for the Gen 2.0 Plant is AU$2.3 million, primarily funded through a previous financing round of C$5,796,000 [1]. - The project is on track to meet its original budget and is expected to be operational by mid-2026, with early work and procurement substantially complete [2]. - The plant will be largely self-powered, utilizing renewable energy sources, an energy storage system, and hydrogen-enriched natural gas from tail gas power generation [3]. Group 2: Financial Performance - GMG reported a significant increase in share price of 178% during Q2 FY2026, reflecting growing market confidence, although this led to a higher calculated fair value for the warrant liability, resulting in a non-cash loss [7]. - As of December 31, 2025, GMG had a cash balance of A$13.9 million, up from A$7.7 million at June 30, 2025, and a positive underlying net assets position of A$21.5 million excluding the warrant liability [11]. - The company's market capitalization was approximately USD$200 million as of December 31, 2025 [8]. Group 3: Non-IFRS Measures and Adjustments - GMG uses EBITDA as a non-IFRS measure to assess operational performance, which is revenue before finance costs, tax, depreciation, and amortization, adjusted for non-cash items [9]. - The adjusted loss for the year was reported at (A$3,597) for the three-month period ended December 31, 2025, with a basic and diluted loss per share of (A$0.1785) [14]. - The company views the warrant liability as a technical accounting matter that does not reflect operational performance or strategic progress [8]. Group 4: Business Objectives and Focus - GMG is focused on developing commercial scale-up capabilities and securing market applications, particularly in energy savings and energy storage solutions [15][16]. - The company is working on graphene-enhanced products for HVAC-R systems and has developed graphene lubricant additives for diesel engines [16]. - Collaborative efforts with the University of Queensland aim to advance R&D and commercialization of graphene aluminium-ion batteries [17].

Fourth-Quarter and Full-Year 2025 Results February 24, 2026 1 Safe harbor Forward-looking statements This document contains, and our officers and representatives may from time to time make, certain "forward-looking statements" within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "anticipate," "intend," "commitment," "look forward," "maintain," "plan," "goal," "seek," "target," "assume," "bel ...

2025 RESULTS RECORD PER SHARE GROWTH February 19, 2026 TSX TFPM | NYSE TFPM February 2026 TRIPLE FLAG PRECIOUS METALS TRIPLE FLAG PRECIOUS METALS CAUTIONARY STATEMENTS This presentation does not constitute an offer to sell or a solicitation of an offer to purchase any security in any jurisdiction Cautionary Note Regarding Forward-Looking Information and Statements: This presentation contains "forward-looking information" within the meaning of applicable Canadian securities laws and "forward-looking statemen ...

Core Viewpoint - Novo Nordisk reported sales growth of 10% and operating profit growth of 6% for 2025 at constant exchange rates, exceeding previous guidance [2][3] Sales and Operating Profit Growth for 2025 - Sales increased by 10% and operating profit increased by 6% compared to guidance of 8 to 11% and 4 to 7% respectively [2] - US Operations benefited from gross-to-net sales adjustments [2] 2026 Sales and Operating Profit Outlook - Sales and operating profit for 2026 will be positively impacted by a reversal of sales rebate provisions of USD 4.2 billion related to the 340B Drug Pricing Program [4] - New non-IFRS measures for adjusted sales and operating profit growth will be introduced to exclude exceptional and non-recurring effects [4][6] - Adjusted sales growth is expected to be between -5% to -13% at constant exchange rates [7][8] - The mid-point of non-adjusted sales and operating profit growth guidance for 2026 is projected at -1% and 11% respectively [6][7] Market Dynamics and Competitive Landscape - The outlook reflects expectations for sales growth in International Operations and a decline in US Operations [9] - Global GLP-1 market expansion is anticipated to continue, increasing patient reach and volumes, but lower realized prices and loss of exclusivity for semaglutide will pose challenges [9][10] - In US Operations, prescription trends and reduced coverage for obesity medication in Medicaid are expected to negatively impact sales [11][12] Investment and R&D Focus - Adjusted operating profit growth is expected to be -5% to -13% at constant exchange rates, with investments in R&D and commercial initiatives funded by savings from a company-wide transformation [13] - R&D investments will focus on expanding the pipeline in Obesity and Diabetes, including the acquisition of Akero Therapeutics, Inc. [13]

Core Insights - California Nanotechnologies Corp. reported revenues of US$392,481 for the quarter ended November 30, 2025, a decrease of 78% compared to the previous year [1] - The company experienced a net loss of US$1,094,650, compared to a net income of US$113,140 in the prior fiscal year, primarily due to delayed manufacturing services revenue and lack of orders from a key client [2][3] - The CEO expressed optimism for the next quarter, anticipating significantly higher revenues and increased visibility on commercial contracts for 2026 [4] Financial Performance - Revenues for the three months ended November 30, 2025, were US$392,481, down from US$1,806,205 in the same period last year, marking a 78% decline [5] - Adjusted EBITDA for the quarter was a loss of US$747,021, compared to a positive Adjusted EBITDA of US$826,454 in the prior year, reflecting a 190% decrease [5] - The gross margin fell to 16% from 77% year-over-year, a decline of 6100 basis points [5] Operational Highlights - The company signed a Letter of Intent to provide commercial Spark Plasma Sintering (SPS) production services for military brake discs, expecting an initial purchase order of US$1 million [8] - Cal Nano announced its first purchase order for nuclear control rods from a U.S.-based small modular nuclear reactor developer, indicating growth potential in the nuclear energy sector [9] - The company is focused on diversifying its client base through R&D and commercial production revenues, aiming to become a trusted supplier for high-value parts [6] Future Outlook - The company expects revenues to exceed US$800,000 in Q4/FY2026 as it executes on delayed revenues and other customer programs [5] - Cal Nano is optimistic about its position in the U.S. SPS market and is deepening relationships with international partners to enhance its supply chain capabilities [10] - The company believes it can recover from the revenue decline associated with its green steel customer and build a more resilient revenue base [11]

Q2 2026 Financial Highlights - Revenue reached $319.0 million, a 15% year-over-year increase[10] - Gross Payment Volume (GPV) grew by 22% year-over-year to $10.8 billion[10] - GPV accounted for 43% of Gross Transaction Volume (GTV)[10] - Gross Transaction Volume (GTV) amounted to $25.3 billion[10] - Recurring subscription and transaction-based revenue represented approximately 97% of total revenue[10] - Average Revenue Per User (ARPU) increased by 15% to approximately $685[10] Financial Outlook - Q3 2026 revenue is projected to be approximately $309 - $312 million[15] - At least 15% year-over-year gross profit growth is expected for Q3 2026[15] - Adjusted EBITDA for Q3 2026 is anticipated to be approximately $18 - $20 million[15] - Fiscal Year 2026 is expected to have at least 12% revenue growth year-over-year[15] - Fiscal Year 2026 is expected to have at least 15% gross profit growth year-over-year[15] - Adjusted EBITDA for Fiscal Year 2026 is projected to be at least $70 million[15]

Financial Performance - The company reported adjusted EBITDA of $77.1 million[33] - The company's cash flow from operations reached $110.3 million[33] - The company's adjusted net income per share was $0.27[33] Production Highlights - Consolidated copper production reached 9,073 ounces[31] - Gold production was 2000 ounces[31] - Caraíba Operations achieved record plant throughput, processing nearly 1.0 million tonnes, a 26% increase compared to Q2 2025[54] - Tucumã Operation saw a 19% sequential quarterly production growth due to higher plant throughput[63] - Xavantina Operations experienced a 17% quarter-over-quarter increase in production, driven by higher processed grades and throughput[72] Strategic Objectives - The company aims to achieve commercial production at Tucumã[36] - The company is focused on deleveraging the balance sheet, with the net debt leverage ratio decreasing to 1.9x at the end of Q3 2025[37] - The company plans to continue gold concentrate sales from Xavantina over the next 12–18 months[43]

Financial Performance - Triple Flag achieved strong financial results in Q3 2025, including 27,037 GEOs[14, 16] - Record adjusted EBITDA of $79 million was achieved[14] - Record operating cash flow of $81 million was achieved[14] - Adjusted EPS increased by 71%[17] - Adjusted EBITDA increased by 27%[17] - Operating Cash Flow per Share increased 26%[17] - Asset margin was 93%[16] Acquisitions and Production - Acquired a 0.8-1.5% NSR royalty package on the Minera Florida mine for $23 million[14] - Over $350 million capital deployed YTD 2025, including a 1.0% NSR royalty on Arthur[14] - Several assets reached first production in H2 2025, including Tres Quebradas (lithium), Johnson Camp Mine (copper cathode), and Sleeping Giant (gold)[14] Portfolio and Strategy - 73% of Q3 2025 revenue was from gold and 27% from silver[20] - 88% of Q3 2025 revenue was from Australia and the Americas[20] - The company expects 2025 GEOs to be between the midpoint and high end of the guidance range of 105,000-115,000 GEOs[14]

Group 1 - The Annual General Meeting of Shareholders is being held virtually, with presentations available in both French and English, including live translation options [1][2] - A playback of the webcast will be accessible on the company's website after the meeting [2] - The company may make forward-looking statements during the meeting, which are subject to risks and uncertainties beyond its control [3]